Stocks · Health care · Biological Products, (No Diagnostic Substances)

Gilead Sciences

GILD Clue Score57

United States Fiscal year ends December CIK 0000882095 Results filed 29 Oct 2026

Add to watchlist

What the insiders did Scheduled selling only

By person

18 insiders · 8 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Daniel Patrick O'Day

Chairman & CEO

—

$5.33M (6) scheduled

−$5.33M

551,683

0.0445%

$94.37M

+11.2%

Andrew D Dickinson

Chief Financial Officer

—

$468.66K (1) scheduled

−$468.66K

161,096

0.0130%

$27.56M

+15.5%

Johanna Mercier

Chief Comm & Corp Aff Officer

—

$468.66K (1) scheduled

−$468.66K

113,684

0.0092%

$19.45M

+45.5%

Merdad Parsey

Chief Medical Officer

—

—

—

82,850

0.0067%

$14.17M

−17.3%

Diane E. Wilfong

Interim Corp Controller & CAO

—

—

—

46,259

0.0037%

$7.91M

+2.6%

Deborah H Telman

EVP, Corporate Affairs & GC

—

—

—

43,676

0.0035%

$7.47M

+104.9%

Sandra Patterson

SVP, Controllership

—

—

—

39,453

0.0032%

$6.75M

+6.9%

Jacqueline K Barton

Director

—

—

—

27,202

0.0022%

$4.65M

+10.8%

Dietmar Berger

Chief Medical Officer

—

—

—

19,522

0.0016%

$3.34M

—

Harish Manwani

Director

—

—

—

15,015

0.0012%

$2.57M

+16.6%

Javier Rodriguez

Director

—

—

—

13,364

0.0011%

$2.29M

+24.9%

Anthony Welters

Director

—

—

—

12,894

0.0010%

$2.21M

+26.0%

Jeffrey Bluestone

Director

—

—

—

10,066

0.0008%

$1.72M

+76.3%

Wettan Keeley M Cain

EVP Gen Counsel, Legal & Comp

—

—

—

8,759

0.0007%

$1.50M

+122.1%

Sandra Horning

Director

—

—

—

6,293

0.0005%

$1.08M

+73.3%

Ted W Love

Director

—

—

—

5,484

0.0004%

$938.11K

+94.3%

Erin Burkhart

SVP, Controllership

—

—

—

1,455

0.0001%

$248.90K

—

Kelly A. Kramer

Director

—

—

—

1,339

0.0001%

$229.05K

0.0%